HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

Abstract
The aim of this study was to investigate the effects of the new estro-progestinic containing the antimineralcorticoid progestogen drospirenone (DRSP) in women with polycystic ovary syndrome (PCOS). Fifteen hirsute PCOS patients were treated with 30 microg ethinyl estradiol plus 3 mg DRSP for 12 cycles. Ultrasonographic pelvic exams, evaluation of hirsutism scores, and hormonal and lipid profile assays were performed at baseline and after three, six, and 12 cycles of treatment. An oral glucose tolerance test and euglycemic hyperinsulinemic clamp were also performed, except at the third cycle. The treatment was well tolerated, and all women attained satisfactory cycle control. Hirsutism significantly improved from the sixth cycle onward. Body weight and fat distribution as well as blood pressure remained stable throughout the treatment. Plasma levels of LH, testosterone, SHBG, and, consequently, the free androgen index significantly fell from the third cycle on. Dehydroepiandrosterone sulfate and 17-hydroxyprogesterone significantly decreased after six cycles. The treatment did not affect glycoinsulinemic homeostasis. A trend toward an increase was seen for total cholesterol, triglycerides, and high- and low-density lipoproteins (HDL and LDL) plasma concentrations, although all parameters remained within the normal range. No modifications in total cholesterol/HDL and HDL/LDL ratios were induced by the therapy. The ethinyl estradiol/DRSP combination seems to be effective in ameliorating clinical and hormonal features of PCOS.
AuthorsM Guido, D Romualdi, M Giuliani, R Suriano, L Selvaggi, R Apa, A Lanzone
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 89 Issue 6 Pg. 2817-23 (Jun 2004) ISSN: 0021-972X [Print] United States
PMID15181063 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Androstenes
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Estrogens
  • Mineralocorticoid Receptor Antagonists
  • Triglycerides
  • Ethinyl Estradiol
  • drospirenone
Topics
  • Adult
  • Androstenes (administration & dosage)
  • Blood Pressure
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Drug Therapy, Combination
  • Estrogens (administration & dosage)
  • Ethinyl Estradiol (administration & dosage)
  • Female
  • Hirsutism (drug therapy, etiology, metabolism)
  • Humans
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists (administration & dosage)
  • Pilot Projects
  • Polycystic Ovary Syndrome (complications, drug therapy, metabolism)
  • Treatment Outcome
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: